These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 39126834)
1. Design and synthesis of TH19P01-Camptothecin based hybrid peptides inducing effective anticancer responses on sortilin positive cancer cells. Li YJ; Fang CB; Wang SS; Chen XQ; Li Y; Liu Q; Qi YK; Du SS Bioorg Med Chem; 2024 Sep; 111():117869. PubMed ID: 39126834 [TBL] [Abstract][Full Text] [Related]
2. TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer. Demeule M; Charfi C; Currie JC; Larocque A; Zgheib A; Kozelko S; Béliveau R; Marsolais C; Annabi B Cancer Sci; 2021 Oct; 112(10):4317-4334. PubMed ID: 34314556 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel HER2 targeting peptide-camptothecin conjugates with effective suppression for selective cancer treatment. Wu H; Liu Y; Zhou J; Meng X; Jiang H; Shi W; Qian H Bioorg Chem; 2024 Jun; 147():107371. PubMed ID: 38643564 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and structural optimization of oncolytic peptide LTX-315. Song M; Liu Q; Yao JF; Wang YT; Ma YN; Xu H; Yu QY; Li Z; Du SS; Qi YK Bioorg Med Chem; 2024 Jun; 107():117760. PubMed ID: 38762978 [TBL] [Abstract][Full Text] [Related]
5. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation. He D; Zhang W; Deng H; Huo S; Wang YF; Gong N; Deng L; Liang XJ; Dong A Chem Commun (Camb); 2016 Dec; 52(98):14145-14148. PubMed ID: 27869268 [TBL] [Abstract][Full Text] [Related]
6. Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation. Li M; Ye W; Fu K; Zhou C; Shi Y; Huang W; Chen W; Hu J; Jiang Z; Zhou W Eur J Med Chem; 2020 Sep; 202():112509. PubMed ID: 32668379 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery. Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents. Zhao XB; Goto M; Song ZL; Morris-Natschke SL; Zhao Y; Wu D; Yang L; Li SG; Liu YQ; Zhu GX; Wu XB; Lee KH Bioorg Med Chem Lett; 2014 Aug; 24(16):3850-3. PubMed ID: 25008456 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity. Yang XY; Zhao HY; Lei H; Yuan B; Mao S; Xin M; Zhang SQ ChemMedChem; 2021 Mar; 16(6):1000-1010. PubMed ID: 33241878 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and cytotoxic activity of novel 7-substituted camptothecin derivatives incorporating piperazinyl-sulfonylamidine moieties. Yang CJ; Song ZL; Goto M; Liu YQ; Hsieh KY; Morris-Natschke SL; Zhao YL; Zhang JX; Lee KH Bioorg Med Chem Lett; 2017 Sep; 27(17):3959-3962. PubMed ID: 28789891 [TBL] [Abstract][Full Text] [Related]
11. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
12. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P. Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel PEG-conjugated 20(S)-camptothecin sulfonylamidine derivatives with potent in vitro antitumor activity via Cu-catalyzed three-component reaction. Song ZL; Chen HL; Wang YH; Goto M; Gao WJ; Cheng PL; Morris-Natschke SL; Liu YQ; Zhu GX; Wang MJ; Lee KH Bioorg Med Chem Lett; 2015 Jul; 25(13):2690-3. PubMed ID: 25987370 [TBL] [Abstract][Full Text] [Related]
14. Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin. Dramou P; Fizir M; Taleb A; Itatahine A; Dahiru NS; Mehdi YA; Wei L; Zhang J; He H Carbohydr Polym; 2018 Oct; 197():117-127. PubMed ID: 30007596 [TBL] [Abstract][Full Text] [Related]
15. Lytic peptide-grafted beta-cyclodextrin polymer based nano-scaled drug delivery system with enhanced camptothecin anti-cancer efficacy. Zhan H; Zhao H; Muhammad N; Li T; Liu Y; Wang J Nanotechnology; 2020 Feb; 31(7):075101. PubMed ID: 31665708 [TBL] [Abstract][Full Text] [Related]
16. Cell penetrating peptide TAT can kill cancer cells via membrane disruption after attachment of camptothecin. Song J; Zhang Y; Zhang W; Chen J; Yang X; Ma P; Zhang B; Liu B; Ni J; Wang R Peptides; 2015 Jan; 63():143-9. PubMed ID: 25496911 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents. Zi CT; Yang L; Xu FQ; Dong FW; Ma RJ; Li Y; Zhou J; Ding ZT; Jiang ZH; Hu JM Bioorg Med Chem Lett; 2019 Jan; 29(2):234-237. PubMed ID: 30509782 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 7-[( Song ZL; Yang GZ; Li JC; Liu YQ; Yang CJ; Goto M; Zhang ZJ; Morris-Natschke SL; Liu H; Lee KH Nat Prod Res; 2020 Jul; 34(14):2022-2029. PubMed ID: 30784310 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antineoplastic activity of novel 20(S)-acylthiourea derivatives of camptothecin. Yang CJ; Li B; Zhang ZJ; Gao JM; Wang MJ; Zhao XB; Song ZL; Liu YQ; Li H; Chen Y; Lee KH; Morris-Natschke SL; Xu C Eur J Med Chem; 2020 Feb; 187():111971. PubMed ID: 31881457 [TBL] [Abstract][Full Text] [Related]
20. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]